Xarelto Compensation Evaluation
Complete this brief survey today to have your case evaluated
Survey Submission Progress:
In January, 2014, the U.S. Food and Drug Administration (FDA) warned of an increased risk of bleeding while taking rivaroxaban (commonly known as Xarelto).
If you or a loved one experienced bleeding or other serious side effects while using Xarelto, please complete this compensation evaluation.
*Source: NY Times 2014 http://goo.gl/FOUAsR